A gene involved in action of tumor promoters is identified and mapped in Caenorhabditis elegans

Carcinogenesis. 1983;4(6):783-6. doi: 10.1093/carcin/4.6.783.

Abstract

We isolated mutants of the nematode Caenorhabditis elegans resistant to 12-O-tetradecanoylphorbol-13-acetate (TPA). The TPA-resistant mutants, although they grew somewhat smaller than normal, reproduced well and behaved normally in TPA; they also did similarly in another phorbol ester tumor promoter, phorbol-12,13-didecanoate (PDD), thus proving they are also resistant to PDD. All the mutations defined by these TPA-resistant mutants were semidominant to the wild-type allele. The 15 independently isolated mutants all fell into the same complementation group, defining a single gene, tpa-1. The gene tpa-1 mapped near the marker gene dpy-9 on chromosome IV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Caenorhabditis / genetics*
  • Chromosome Mapping
  • Drug Resistance
  • Genes / drug effects*
  • Mutation
  • Phorbol Esters / pharmacology
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Phorbol Esters
  • phorbol-12,13-didecanoate
  • Tetradecanoylphorbol Acetate